CHADDS FORD, PA--(Marketwire - May 22, 2008) - Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) today announced that Blaine T. Davis has been appointed Vice President, Investor Relations and Corporate Communications. Mr. Davis will be responsible for the creation and implementation of strategic communications efforts that support Endo's business objectives to all key stakeholders, including investors, employees and the media. He will report directly to the President and Chief Executive Officer David P. Holveck.
